A
Anne-Marie Bagnall
Researcher at Leeds Beckett University
Publications - 107
Citations - 3863
Anne-Marie Bagnall is an academic researcher from Leeds Beckett University. The author has contributed to research in topics: Psychological intervention & Health care. The author has an hindex of 28, co-authored 100 publications receiving 3501 citations. Previous affiliations of Anne-Marie Bagnall include University of York & Universities UK.
Papers
More filters
Journal ArticleDOI
Interventions for the Treatment and Management of Chronic Fatigue Syndrome: A Systematic Review
Penny Whiting,Anne-Marie Bagnall,Amanda Sowden,John E. Cornell,Cynthia Mulrow,Cynthia Mulrow,Gilbert Ramirez +6 more
TL;DR: To assess the effectiveness of all interventions that have been evaluated for use in the treatment or management of CFS in adults or children, 350 studies initially identified demonstrated mixed results in terms of effectiveness.
Journal ArticleDOI
How effective are patient-based educational interventions in the management of cancer pain? Systematic review and meta-analysis.
TL;DR: Patient‐based educational interventions can result in modest but significant benefits in the management of cancer pain, and are probably underused alongside more traditional analgesic approaches.
Interventions for the Treatment, Management and Rehabilitation of Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis
TL;DR: In this paper, the authors conducted a systematic review to determine whether any particular intervention or combination of interventions is effective in the treatment, management and rehabilitation of adults and children with a diagnosis of chronic fatigue syndrome / myalgic encephalomyelitis (CFS/ME).
Journal ArticleDOI
Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.
TL;DR: Some behavioural interventions have shown promising results in reducing the symptoms of CFS/ME and improving physical functioning and there is a need for research to define the characteristics of patients who would benefit from specific interventions and to develop clinically relevant objective outcome measures.
Journal ArticleDOI
A systematic review of atypical antipsychotic drugs in schizophrenia.
Anne-Marie Bagnall,Lisa Jones,Laura Ginnelly,Ruth Lewis,Julie Glanville,Simon Gilbody,L. Davies,David J. Torgerson,Jos Kleijnen +8 more
TL;DR: The main objectives were to assess the clinical effectiveness, safety and cost-effectiveness of 'atypical' antipsychotic drugs in schizophrenia in comparison with conventional anti-schizophrenia drugs, placebo and other atypical antipsychotics.